Clinical Assistant Professor, Pediatrics - Immunology and Allergy
Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.
Some breast cancers return decades later. Now, a researcher at Stanford, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.
Some viruses sequester antibiotics in the lungs of CF patients, possibly helping drug-resistant bacterial infections develop in the face of large antibiotic doses, a Stanford-led study has shown.
Stanford Medicine is leading the biomedical revolution to improve health, defining and developing care that is proactive, predictive and precise
Innovative programs ensure diversity is reflected in our programs, culture and leadership.
Nobel laureate Arthur Kornberg creates a strand of biologically active DNA, paving the way for studies of genetics.
Norman Shumway successfully transplants a heart into 54-year-old steelworker Mike Kasperak, who survives for 14 days.
Geneticist Stanely Cohen transfers a foreign gene into bacterial cells, which then express the gene.
Mary Gohlke receives the world's first combined heart and lung transplant in a landmark operation led by surgeon Bruce Reitz.
Immunologist Mark Davis characterizes the T-cell receptor, believed to regulate the body's response to infectious agents and cancerous diseases.
Pathologist Irving Weissman isolates a rare mouse cell, known as the hematopoetic stem cell, which gives rise to all the cells of the blood and immune systems.
Bioengineer Karl Deisseroth and his team develop a technique known as optogenetics that allows them to genetically alter brain cell activity in mice with light.